BANK OF AMERICA CORP /DE/ - GALENA BIOPHARMA INC ownership

GALENA BIOPHARMA INC's ticker is GALE and the CUSIP is 363256504. A total of 51 filers reported holding GALENA BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q3 2017$0500
+4445.5%
0.00%
Q2 2017$0
-100.0%
11
-99.9%
0.00%
Q1 2017$5,000
+66.7%
8,024
+440.7%
0.00%
Q4 2016$3,0001,4840.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
EQUITEC SPECIALISTS, LLC 358,600$696,0000.17%
ARXIS SECURITIES LLC 13,039$25,0000.03%
EQUITEC SPECIALISTS, LLC 65,600$127,0000.03%
Acrospire Investment Management LLC 13,100$25,0000.01%
Virtu KCG Holdings LLC 60,313$117,0000.00%
INTEGRAL DERIVATIVES, LLC 72,200$140,0000.00%
SABBY MANAGEMENT, LLC 23,298$45,0000.00%
WOLVERINE TRADING, LLC 229,400$445,0000.00%
Tower Research Capital LLC (TRC) 10,339$20,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 1,030,800$2,000,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders